Skip to search formSkip to main contentSkip to account menu

Colestipol

Known as: Colestipol [Chemical/Ingredient], Epichlorohydrin-tetraethylenepentamine polymer, Colestipolum 
A positively charged, non-digestible, triamine and epoxypropane copolymer anion-exchange resin that binds to bile acids in the intestine to form an… 
National Institutes of Health

Related topics

Related topics

22 relations

Broader (4)

Anion Exchange ResinsAntilipemic agentHypolipidemic AgentsSequestering Agents
Binding Activity [MoA]Cholestasis, ExtrahepaticColestipol HydrochlorideColestipol Hydrochloride 1000 MG Oral Tablet [Colestid]

Narrower (1)

Colestid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1987
1987
Alterations in serum thyroid hormonal indices with colestipol-niacin therapy.
A serial blood-lipid-lowering study at the University of Southern California yielded unexpected findings on routine thyroid… 
1985
1985
Weight loss improves lipoprotein lipid profiles in patients with hypercholesterolemia.
Risk for coronary artery disease is directly related to plasma levels of total and low-density lipoprotein (LDL) cholesterol and… 
1983
1983
Effect of cholestyramine and colestipol on the absorption of phenytoin
SummaryThe hypocholesterolemic cation resins, cholestyramine and colestipol, have variable effects on the absorption parameters… 
1983
1983
Effects of hypolipidemic therapy on cholesterol homeostasis in freshly isolated mononuclear cells from patients with heterozygous familial hypercholesterolemia.
Freshly isolated mononuclear leukocytes have been reported to show changes in cholesterol synthesis and high-affinity degradation… 
Review
1982
Review
1982
Colestipol and probucol: treatment of primary and familial hypercholesterolemia and amelioration of atherosclerosis.
Colestipol is a safe, effective, cholesterol-lowering, bile-acid sequestrant that lowers low-density-lipoprotein (LDL) and total… 
1982
1982
Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
When probucol in therapeutic doses is added to the therapeutic regimen of patients previously treated with colestipol and diet… 
1978
1978
[A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
Plasma lipids and lipoproteins were studied in 20 children and adolescents with familial hypercholesterolemia during the… 
1977
1977
[Colestipol by hypercholesteremia in diabetics].
The study comprises 90 diabetic patients with hypercholesterolemia. They received colestipol, a basic anion exchange resin, which… 
Highly Cited
1976
Highly Cited
1976
The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
Bile acid-binding resins, currently used for the treatment of Type II hyperlipoproteinemia, decrease LDL cholesterol by 25 to 35… 
1976
1976
The effect of colestipol on digitoxin plasma levels.
: The effect of colestipol (colestipol hydrochloride; U-26 597 A), a copolymer of tetraethylenepentamine and epichlorhydrine, on…